COVID‐19 vaccines—The way forward

Author:

Klimek Ludger1ORCID,Agache Ioana2ORCID,Cooke Emer3ORCID,Jutel Marek45ORCID,Akdis Cezmi A.6ORCID,O'Hehir Robyn78ORCID

Affiliation:

1. Center for Rhinology and Allergology Wiesbaden Germany

2. Faculty of Medicine Transylvania University Brasov Romania

3. European Medicines Agency Amsterdam Netherlands

4. Department of Clinical Immunology Wroclaw Medical University Wroclaw Poland

5. All‐MED Medical Research Institute Wroclaw Poland

6. Swiss Institute of Allergy and Asthma Research (SIAF) University of Zurich Davos Switzerland

7. Department of Immunology and Pathology Monash University Melbourne Vic. Australia

8. Department of Allergy, Immunology and Respiratory Medicine Central Clinical School Monash Vic. Australia

Publisher

Wiley

Reference9 articles.

1. Navigating facilitated regulatory pathways during a disease X pandemic

2. Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID‐19 vaccines in Europe

3. The race to produce COVID‐19 vaccines is a chance to create a more harmonized approvals process;Eyes of the world are on medicines regulators;Nature,2020

4. COVID‐19 vaccines undergoing evaluation.2021.

5. Vaccine safety basics e‐learning course.2021.

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3